Exact Mass: 311.2647

Exact Mass Matches: 311.2647

Found 133 metabolites which its exact mass value is equals to given mass value 311.2647, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Biperiden

1-{bicyclo[2.2.1]hept-5-en-2-yl}-1-phenyl-3-(piperidin-1-yl)propan-1-ol

C21H29NO (311.2249)


A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine. [PubChem] D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent Biperiden (KL 373) is a non-selective muscarinic receptor antagonist that competitively binds to M1 muscarinic receptors, thereby inhibiting acetylcholine and enhancing dopamine signaling in the central nervous system. Biperiden has the potential for the research of Parkinson's disease and other related psychiatric disorders[1][2].

   

1-[(1R,4R)-5-bicyclo[2.2.1]hept-2-enyl]-1-phenyl-3-(1-piperidinyl)-1-propanol

1-[(1R,4R)-5-bicyclo[2.2.1]hept-2-enyl]-1-phenyl-3-(1-piperidinyl)-1-propanol

C21H29NO (311.2249)


   

(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C21H29NO (311.2249)


   

1-(1-Pentyl-1h-indol-3-yl)-3-methyl-2-(propan-2-yl)but-3-en-1-one

1-(1-Pentyl-1h-indol-3-yl)-3-methyl-2-(propan-2-yl)but-3-en-1-one

C21H29NO (311.2249)


   

13-Azaprostanoic acid

7-[2-(heptylamino)cyclopentyl]heptanoic acid

C19H37NO2 (311.2824)


   

Dimepheptanol

(3R,6R)-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane

C21H29NO (311.2249)


   

(9S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoate

(10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid

C18H31O4 (311.2222)


(9s,10e,12z)-9-hydroperoxy-10,12-octadecadienoate, also known as 9(S)-hydroperoxy-10(E),12(z)-octadecadienoic acid or 9(S)-hpod(1-), belongs to lineolic acids and derivatives class of compounds. Those are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions (9s,10e,12z)-9-hydroperoxy-10,12-octadecadienoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (9s,10e,12z)-9-hydroperoxy-10,12-octadecadienoate can be found in a number of food items such as mexican groundcherry, brazil nut, coconut, and winter savory, which makes (9s,10e,12z)-9-hydroperoxy-10,12-octadecadienoate a potential biomarker for the consumption of these food products.

   

(Z)-1-Methyl-2-(undec-5-enyl)quinolin-4-one

(Z)-1-Methyl-2-(undec-5-enyl)quinolin-4-one

C21H29NO (311.2249)


   

Malouetafrine

Malouetafrine

C21H29NO (311.2249)


   
   

1-Methyl-2-[(Z)-6-undecenyl]quinolin-4-one

1-Methyl-2-[(Z)-6-undecenyl]quinolin-4-one

C21H29NO (311.2249)


   
   

UNII-L26S4AX8CG

UNII-L26S4AX8CG

C21H29NO (311.2249)


   

N-Tetradecanoyl-DL-homoserine lactone

N-Tetradecanoyl-DL-homoserine lactone

C18H33NO3 (311.246)


   

Kalihipyran

Kalihipyran

C21H29NO (311.2249)


   
   
   

Cyclo-(leucyl=>valyl=>valyl)

Cyclo-(leucyl=>valyl=>valyl)

C16H29N3O3 (311.2209)


   

seco-pseudopteroxazole

seco-pseudopteroxazole

C21H29NO (311.2249)


A natural product found in Pseudopterogorgia elisabethae.

   

1-methyl-2-[(E)-1-undecenyl]-4(1H)-quinolone|1-methyl-2-[(E)-1-undecenyl]-4(1H)-quinolone

1-methyl-2-[(E)-1-undecenyl]-4(1H)-quinolone|1-methyl-2-[(E)-1-undecenyl]-4(1H)-quinolone

C21H29NO (311.2249)


   

norholadiene

norholadiene

C21H29NO (311.2249)


   

(-)-(3Xi)-12-((rel-2R)-5c-hydroxy-6c-methyl-piperidin-2-yl)-3-methyl-dodecan-2-one|Cassin

(-)-(3Xi)-12-((rel-2R)-5c-hydroxy-6c-methyl-piperidin-2-yl)-3-methyl-dodecan-2-one|Cassin

C19H37NO2 (311.2824)


   

1-Methyl-2-(undec-6-en-1-yl)quinolin-4(1H)-one

1-Methyl-2-(undec-6-en-1-yl)quinolin-4(1H)-one

C21H29NO (311.2249)


   

(±)13-Azaprostanoic acid

(±)13-Azaprostanoic acid

C19H37NO2 (311.2824)


   

1-methyl-2-undec-6-enylquinolin-4-one

1-Methyl-2-(undec-6-en-1-yl)quinolin-4(1H)-one

C21H29NO (311.2249)


   

1-Methyl-2-[(Z)-5-undecenyl]-4(1H)-quinolone

4(1H)-Quinolinone, 1-methyl-2-(5Z)-5-undecen-1-yl-

C21H29NO (311.2249)


   

C21H29NO_1-Methyl-2-[(6Z)-6-undecen-1-yl]-4(1H)-quinolinone

NCGC00385992-01_C21H29NO_1-Methyl-2-[(6Z)-6-undecen-1-yl]-4(1H)-quinolinone

C21H29NO (311.2249)


   

(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C21H29NO (311.2249)


   

C14-homoserine lactone

N-(2-oxooxolan-3-yl)tetradecanamide

C18H33NO3 (311.246)


CONFIDENCE standard compound; INTERNAL_ID 206

   

biperiden

biperiden

C21H29NO (311.2249)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent Biperiden (KL 373) is a non-selective muscarinic receptor antagonist that competitively binds to M1 muscarinic receptors, thereby inhibiting acetylcholine and enhancing dopamine signaling in the central nervous system. Biperiden has the potential for the research of Parkinson's disease and other related psychiatric disorders[1][2].

   

deoxycommendamide (putative) or in source fragment -H2O observed in AGP sample

deoxycommendamide (putative) or in source fragment -H2O observed in AGP sample

C18H33NO3 (311.246)


   

(dehydrohexadecanoyl)glycine - Commendamide analogue

(dehydrohexadecanoyl)glycine - Commendamide analogue

C18H33NO3 (311.246)


   

(7R,8R,E)-6-((2R)-7-hydroxy-2,6-dimethylheptylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((2R)-7-hydroxy-2,6-dimethylheptylidene)-8-methyloctahydroindolizine-7,8-diol

C18H33NO3 (311.246)


   

(±)13-Azaprostanoic acid

(±)13-Azaprostanoic acid

C19H37NO2 (311.2824)


   

9-methyl-sphinga-4E,8E-dienine

9-methyl-sphinga-4E,8E-dienine

C19H37NO2 (311.2824)


   

TDHL

N-[(3S)-tetrahydro-2-oxo-3-furanyl]-tetradecanamide

C18H33NO3 (311.246)


   

C14-HSL

N-tetradecanoyl-homoserine lactone

C18H33NO3 (311.246)


   

SPB 19:2;O2

9-methyl-sphinga-4E,8E-dienine

C19H37NO2 (311.2824)


   

Alphamethadol

Alphamethadol

C21H29NO (311.2249)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

1-Tetradecylpyridinium chloride

1-Tetradecylpyridinium chloride

C19H34ClN (311.238)


   

Bufenadrine

Bufenadrine

C21H29NO (311.2249)


   

tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate

tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate

C16H30BNO4 (311.2268)


   

(3S,6R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanol

(3S,6R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanol

C21H29NO (311.2249)


   
   

Benzyldimethyldecylammonium chloride purum,

Benzyldimethyldecylammonium chloride purum,

C19H34ClN (311.238)


   

Benzyltributylammonium chloride

Benzyltributylammonium chloride

C19H34ClN (311.238)


   

1-Isothiocyanatooctadecane

1-Isothiocyanatooctadecane

C19H37NS (311.2647)


   

Methyl undecenoyl leucinate

Methyl undecenoyl leucinate

C18H33NO3 (311.246)


   

(Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one

(Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one

C21H29NO (311.2249)


   
   

13(S)-Hpode(1-)

13(S)-Hpode(1-)

C18H31O4- (311.2222)


Conjugate base of 13(S)-HPODE arising from deprotonation of the carboxylic acid function.

   

Phytanate

Phytanate

C20H39O2- (311.295)


A branched-chain saturated fatty acid anion that is the conjugate base of phytanic acid, arising from deprotonation of the carboxylic acid group.

   

(9S,10E,12Z)-9-Hydroperoxy-10,12-octadecadienoate

(9S,10E,12Z)-9-Hydroperoxy-10,12-octadecadienoate

C18H31O4- (311.2222)


   

(8R,9Z,12Z)-8-Hydroperoxyoctadeca-9,12-dienoate

(8R,9Z,12Z)-8-Hydroperoxyoctadeca-9,12-dienoate

C18H31O4- (311.2222)


   

(11S)-11-Hydroperoxylinoleate

(11S)-11-Hydroperoxylinoleate

C18H31O4- (311.2222)


Conjugate base of (11S)-11-hydroperoxylinoleic acid arising from deprotonation of the carboxylic acid function.

   

(9R,10E,12Z)-9-hydroperoxyoctadeca-10,12-dienoate

(9R,10E,12Z)-9-hydroperoxyoctadeca-10,12-dienoate

C18H31O4- (311.2222)


   

5(S),8(R)-DiHODE(1-)

5(S),8(R)-DiHODE(1-)

C18H31O4- (311.2222)


A monocarboxylic acid anion resulting from the deprotonation of the carboxy group of 5(S),8(R)-DiHODE. The major species at pH 7.3.

   

(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate

(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate

C18H31O4- (311.2222)


The hydroperoxy fatty acid anion that is the conjugate base of hydroperoxy fatty acid anion, formed by deprotonation of the carboxy group; principal microspecies at pH 7.3.

   

(8E,10S,12Z)-10-hydroperoxyoctadeca-8,12-dienoate

(8E,10S,12Z)-10-hydroperoxyoctadeca-8,12-dienoate

C18H31O4- (311.2222)


An unsaturated fatty acid anion that is the conjugate base of (8E,10S,12Z)-10-hydroperoxyoctadeca-8,12-dienoic acid, obtained by deprotonation of the carboxy group.

   

(12Z,15Z)-9,10-dihydroxyoctadeca-12,15-dienoic acid

(12Z,15Z)-9,10-dihydroxyoctadeca-12,15-dienoic acid

C18H31O4- (311.2222)


   

9-Hydroxy-10-oxo-12-octadecenoate

9-Hydroxy-10-oxo-12-octadecenoate

C18H31O4- (311.2222)


   

(9Z,11E,13R)-13-hydroperoxyoctadecadienoate

(9Z,11E,13R)-13-hydroperoxyoctadecadienoate

C18H31O4- (311.2222)


   

(9Z,15Z)-12,13-Dihydroxyoctadeca-9,15-dienoate

(9Z,15Z)-12,13-Dihydroxyoctadeca-9,15-dienoate

C18H31O4- (311.2222)


   

(9Z,12Z)-15,16-Dihydroxyoctadeca-9,12-dienoate

(9Z,12Z)-15,16-Dihydroxyoctadeca-9,12-dienoate

C18H31O4- (311.2222)


   

8-[3-[(3-Pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoate

8-[3-[(3-Pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoate

C18H31O4- (311.2222)


   

10-oxo-13-Hydroxy-11-octadecenoate

10-oxo-13-Hydroxy-11-octadecenoate

C18H31O4- (311.2222)


   

(7S,8S,9Z,12Z)-7,8-dihydroxy-9,12-octadecadienoate

(7S,8S,9Z,12Z)-7,8-dihydroxy-9,12-octadecadienoate

C18H31O4- (311.2222)


   

13-HPODE(1-)

13-HPODE(1-)

C18H31O4- (311.2222)


A hydroperoxy fatty acid anion that is the conjugate base of 13-HPODE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

9-hydroperoxy-(10E,12Z)-octadecadienoate

9-hydroperoxy-(10E,12Z)-octadecadienoate

C18H31O4- (311.2222)


   

Palmitoleoylglycine

Palmitoleoylglycine

C18H33NO3 (311.246)


   

7(S),8(S)-DiHODE(1-)

7(S),8(S)-DiHODE(1-)

C18H31O4- (311.2222)


Conjugate base of 7(S),8(S)-DiHODE arising from deprotonation of the carboxylic acid function.

   

1-(1-Methylcyclopentyl)-1-phenyl-4-(1-piperidinyl)-2-butyn-1-ol

1-(1-Methylcyclopentyl)-1-phenyl-4-(1-piperidinyl)-2-butyn-1-ol

C21H29NO (311.2249)


   

11-hydroxy-(12S,13S)-epoxy-(9Z)-octadecenoate(1-)

11-hydroxy-(12S,13S)-epoxy-(9Z)-octadecenoate(1-)

C18H31O4- (311.2222)


A monounsaturated fatty acid anion that is the conjugate base of 11-hydroxy-(12S,13S)-epoxy-(9Z)-octadecenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(11R)-hydroperoxy-(9Z,12Z)-octadecadienoate

(11R)-hydroperoxy-(9Z,12Z)-octadecadienoate

C18H31O4- (311.2222)


   

(2R,9Z,12Z)-2-hydroperoxyoctadecadienoate

(2R,9Z,12Z)-2-hydroperoxyoctadecadienoate

C18H31O4- (311.2222)


   

8-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}octanoate

8-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}octanoate

C18H31O4- (311.2222)


   

(9Z)-11-[3-(5-hydroxypentyl)oxiran-2-yl]undec-9-enoate

(9Z)-11-[3-(5-hydroxypentyl)oxiran-2-yl]undec-9-enoate

C18H31O4- (311.2222)


   

1-[(1S,4S)-2-bicyclo[2.2.1]hept-5-enyl]-1-phenyl-3-piperidin-1-ylpropan-1-ol

1-[(1S,4S)-2-bicyclo[2.2.1]hept-5-enyl]-1-phenyl-3-piperidin-1-ylpropan-1-ol

C21H29NO (311.2249)


   

(dehydrohexadecanoyl)glycine-Commendamide analogue

(dehydrohexadecanoyl)glycine-Commendamide analogue

C18H33NO3 (311.246)


   

7,8-dihydroxy-(9Z,12Z)-octadecadienoate

7,8-dihydroxy-(9Z,12Z)-octadecadienoate

C18H31O4- (311.2222)


   

(5S)-hydroperoxy-(6E,8Z)-octadecadienoate

(5S)-hydroperoxy-(6E,8Z)-octadecadienoate

C18H31O4- (311.2222)


   

(10R,11R)-epoxy-(9S)-hydroxy-(12Z)-octadecenoate

(10R,11R)-epoxy-(9S)-hydroxy-(12Z)-octadecenoate

C18H31O4- (311.2222)


   

(12S,13R)-epoxy-(10R)-hydroxy-(8E)-octadecenoate

(12S,13R)-epoxy-(10R)-hydroxy-(8E)-octadecenoate

C18H31O4- (311.2222)


   

(12R,13R)-epoxy-(11S)-hydroxy-(9Z)-octadecenoate

(12R,13R)-epoxy-(11S)-hydroxy-(9Z)-octadecenoate

C18H31O4- (311.2222)


   

(5S,18)-dihydroxy-(6E,8Z)-octadecadienoate

(5S,18)-dihydroxy-(6E,8Z)-octadecadienoate

C18H31O4- (311.2222)


   

(11S)-hydroxy-(9S,10S)-epoxy-(12Z)-octadecenoate

(11S)-hydroxy-(9S,10S)-epoxy-(12Z)-octadecenoate

C18H31O4- (311.2222)


   

(12S,13S)-epoxy-(11R)-hydroxy-(9Z)-octadecenoate

(12S,13S)-epoxy-(11R)-hydroxy-(9Z)-octadecenoate

C18H31O4- (311.2222)


   

(11R)-hydroxy-(9S,10S)-epoxy-(12Z)-octadecenoate

(11R)-hydroxy-(9S,10S)-epoxy-(12Z)-octadecenoate

C18H31O4- (311.2222)


   

11-Hydroxy-12,13-epoxy-(9cis)-octadecenoate

11-Hydroxy-12,13-epoxy-(9cis)-octadecenoate

C18H31O4- (311.2222)


   

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]propanamide

C18H33NO3 (311.246)


   

N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]acetamide

C18H33NO3 (311.246)


   

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]pentanamide

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]pentanamide

C18H33NO3 (311.246)


   

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]butanamide

C18H33NO3 (311.246)


   

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]hexanamide

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]hexanamide

C18H33NO3 (311.246)


   

3-(1,3,6-Trimethyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

3-(1,3,6-Trimethyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

C20H29N3 (311.2361)


   

(Z)-N-(2-hydroxyethyl)heptadec-9-enamide

(Z)-N-(2-hydroxyethyl)heptadec-9-enamide

C19H37NO2 (311.2824)


   

Icosanoate

Icosanoate

C20H39O2 (311.295)


A long-chain fatty acid anion resulting from the removal of a proton from the carboxy group of icosanoic acid (arachidic acid).

   

9(S)-HPODE(1-)

9(S)-HPODE(1-)

C18H31O4 (311.2222)


A monocarboxylic acid anion obtained by removal of a proton from the carboxylic acid group of 9(S)-HPODE.

   

8(R)-HPODE(1-)

8(R)-HPODE(1-)

C18H31O4 (311.2222)


A monocarboxylic acid anion resulting from the deprotonation of the carboxy group of 8(R)-HPODE. The major species at pH 7.3.

   

9(R)-HPODE(1-)

9(R)-HPODE(1-)

C18H31O4 (311.2222)


A monocarboxylic acid anion obtained by removal of a proton from the carboxylic acid group of 9(R)-HPODE.

   

13(R)-HPODE(1-)

13(R)-HPODE(1-)

C18H31O4 (311.2222)


A 13-HPODE(1-) that is the conjugate base of 13(R)-HPODE, obtained by deprotonation of the carboxylic acid function. Major microspecies at pH 7.3.

   

(4E,8E,9Me-d19:2)sphingosine

(4E,8E,9Me-d19:2)sphingosine

C19H37NO2 (311.2824)


   

N-(2-oxooxolan-3-yl)tetradecanamide

N-(2-oxooxolan-3-yl)tetradecanamide

C18H33NO3 (311.246)


   

N-[(9Z)-hexadecenoyl]glycine

N-[(9Z)-hexadecenoyl]glycine

C18H33NO3 (311.246)


A fatty acid amide resulting from the formal condensation of the carboxy group of (9Z)-hexadecenoic acid with the amino group of glycine.

   

fatty acid anion 20:0

fatty acid anion 20:0

C20H39O2 (311.295)


Any saturated fatty acid anion containing 20 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.

   

Sphingosine (d19:2)

SPH(d19:2)

C19H37NO2 (311.2824)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Ala 15:1(9Z)

NA-Ala 15:1(9Z)

C18H33NO3 (311.246)


   

NA-Gly 16:1(9Z)

NA-Gly 16:1(9Z)

C18H33NO3 (311.246)


   

10Z-Heptadecenoyl-EA

10Z-Heptadecenoyl-EA

C19H37NO2 (311.2824)


   

(4E,8E,9Me-d19:2) Sphingosine

(4E,8E,9Me-d19:2) Sphingosine

C19H37NO2 (311.2824)


   

12-[(2s,5s,6s)-5-hydroxy-1,6-dimethylpiperidin-2-yl]dodecan-2-one

12-[(2s,5s,6s)-5-hydroxy-1,6-dimethylpiperidin-2-yl]dodecan-2-one

C19H37NO2 (311.2824)


   

1-methyl-2-(5-undecenyl)-4(1h)-quinolinone

NA

C21H29NO (311.2249)


{"Ingredient_id": "HBIN002732","Ingredient_name": "1-methyl-2-(5-undecenyl)-4(1h)-quinolinone","Alias": "NA","Ingredient_formula": "C21H29NO","Ingredient_Smile": "NA","Ingredient_weight": "311.466","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9165","PubChem_id": "NA","DrugBank_id": "NA"}

   

1-methyl-2-(6-undecenyl)-4(1h)-quinolinone

NA

C21H29NO (311.2249)


{"Ingredient_id": "HBIN002735","Ingredient_name": "1-methyl-2-(6-undecenyl)-4(1h)-quinolinone","Alias": "NA","Ingredient_formula": "C21H29NO","Ingredient_Smile": "NA","Ingredient_weight": "311.466","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9162","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-ethyl-n-{[(2-ethyl-1-hydroxyhexylidene)amino]methanimidoyl}hexanimidic acid

2-ethyl-n-{[(2-ethyl-1-hydroxyhexylidene)amino]methanimidoyl}hexanimidic acid

C17H33N3O2 (311.2573)


   

6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

C21H29NO (311.2249)


   

12-(5-hydroxy-6-methylpiperidin-2-yl)-3-methyldodecan-2-one

12-(5-hydroxy-6-methylpiperidin-2-yl)-3-methyldodecan-2-one

C19H37NO2 (311.2824)


   

4,9-dimethyl-6-(6-methylhept-5-en-2-yl)-6h,7h,8h,9h-naphtho[2,1-d][1,3]oxazole

4,9-dimethyl-6-(6-methylhept-5-en-2-yl)-6h,7h,8h,9h-naphtho[2,1-d][1,3]oxazole

C21H29NO (311.2249)


   

(2r)-2-ethyl-n-({[(2r)-2-ethyl-1-hydroxyhexylidene]amino}methanimidoyl)hexanimidic acid

(2r)-2-ethyl-n-({[(2r)-2-ethyl-1-hydroxyhexylidene]amino}methanimidoyl)hexanimidic acid

C17H33N3O2 (311.2573)


   

11-[1-(1,3-oxazolidin-2-yl)pyrrolidin-2-yl]undecan-2-amine

11-[1-(1,3-oxazolidin-2-yl)pyrrolidin-2-yl]undecan-2-amine

C18H37N3O (311.2936)


   

n-[(3s)-2-oxooxolan-3-yl]tetradecanimidic acid

n-[(3s)-2-oxooxolan-3-yl]tetradecanimidic acid

C18H33NO3 (311.246)


   

(1r,2s,5s,6s,9r,12s,13r)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

(1r,2s,5s,6s,9r,12s,13r)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

C21H29NO (311.2249)


   

2-[3-(2-hexylcyclopropyl)propyl]-1h-quinolin-4-one

2-[3-(2-hexylcyclopropyl)propyl]-1h-quinolin-4-one

C21H29NO (311.2249)


   

1-isocyano-1,6-dimethyl-4-[6-(prop-1-en-2-yl)-5,6-dihydro-2h-pyran-3-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalene

1-isocyano-1,6-dimethyl-4-[6-(prop-1-en-2-yl)-5,6-dihydro-2h-pyran-3-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalene

C21H29NO (311.2249)


   

(1s,4s,4as,8as)-1,6-dimethyl-4-[(6s)-6-(prop-1-en-2-yl)-5,6-dihydro-2h-pyran-3-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalene-1-carbonitrile

(1s,4s,4as,8as)-1,6-dimethyl-4-[(6s)-6-(prop-1-en-2-yl)-5,6-dihydro-2h-pyran-3-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalene-1-carbonitrile

C21H29NO (311.2249)


   

(3s)-12-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]-3-methyldodecan-2-one

(3s)-12-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]-3-methyldodecan-2-one

C19H37NO2 (311.2824)


   

(6r,9s)-4,9-dimethyl-6-[(2s)-6-methylhept-5-en-2-yl]-6h,7h,8h,9h-naphtho[2,1-d][1,3]oxazole

(6r,9s)-4,9-dimethyl-6-[(2s)-6-methylhept-5-en-2-yl]-6h,7h,8h,9h-naphtho[2,1-d][1,3]oxazole

C21H29NO (311.2249)


   

(2r)-2-ethyl-n-({[(2s)-2-ethyl-1-hydroxyhexylidene]amino}methanimidoyl)hexanimidic acid

(2r)-2-ethyl-n-({[(2s)-2-ethyl-1-hydroxyhexylidene]amino}methanimidoyl)hexanimidic acid

C17H33N3O2 (311.2573)


   

1,6-dimethyl-4-[6-(prop-1-en-2-yl)-5,6-dihydro-2h-pyran-3-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalene-1-carbonitrile

1,6-dimethyl-4-[6-(prop-1-en-2-yl)-5,6-dihydro-2h-pyran-3-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalene-1-carbonitrile

C21H29NO (311.2249)


   

6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-17,19-dien-16-one

6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-17,19-dien-16-one

C21H29NO (311.2249)


   

(1r,2s,5s,6s,9r,12s,13r)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,17-dien-16-one

(1r,2s,5s,6s,9r,12s,13r)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,17-dien-16-one

C21H29NO (311.2249)


   

(8ar)-6,8a-diisopropyl-2,2,4-trimethyl-8h,9h-cyclopenta[g]quinolin-7-one

(8ar)-6,8a-diisopropyl-2,2,4-trimethyl-8h,9h-cyclopenta[g]quinolin-7-one

C21H29NO (311.2249)


   

n-(2-oxooxolan-3-yl)tetradecanimidic acid

n-(2-oxooxolan-3-yl)tetradecanimidic acid

C18H33NO3 (311.246)


   

(1r,2s,5s,6s,9r,12s,13r)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-17,19-dien-16-one

(1r,2s,5s,6s,9r,12s,13r)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-17,19-dien-16-one

C21H29NO (311.2249)